Accordingly, any drug combinations that could reduce the levels of TGF-β, IL-10, and Foxp3 and increase the level of IFNγ, would have a potent inhibitory effect on tumor growth (44, 58-61). This evidence concerns the gene TGFB1 and neoplasm.